Location History:
- Ridgefield, CT (US) (1990)
- Newtown, CT (US) (1994 - 2000)
Company Filing History:
Years Active: 1990-2000
Title: Innovations in Nucleic Acid Amplification: The Contributions of Enrico G. Picozza
Introduction
Enrico G. Picozza, an accomplished inventor based in Ridgefield, CT, has made significant contributions in the field of nucleic acid amplification. With a total of seven patents to his name, he has advanced the methodologies utilized in polymerase chain reaction (PCR) technology, which plays a crucial role in genetic analysis and diagnostics.
Latest Patents
Among his latest innovations is the patent for a "Nucleic Acid Amplification Reaction Apparatus and Method." This invention describes an apparatus designed for conducting nucleic acid amplification reactions, specifically focusing on the polymerase chain reaction (PCR). The apparatus is characterized by several embodiments; for example, one embodiment features a capillary tube loop that cycles samples through two thermostatted fluid baths. Another design ensures the effective routing of the capillary tube between two heat exchangers, allowing the sample to pass through efficiently. Additional embodiments propose varying methods of maintaining heat exchangers stationary while translating or rotating samples, all aimed at achieving the thermal cycles necessary for amplification.
Career Highlights
Enrico is currently associated with the PerkinElmer Corporation, where he leverages his expertise in developing innovative solutions for nucleic acid amplification. His work has not only contributed to the scientific community but has also enhanced the capabilities of diagnostic techniques in various sectors.
Collaborations
Throughout his career, Enrico has collaborated with notable colleagues such as Timothy M. Woudenberg and Lawrence A. Haff. These partnerships have fostered an environment of creativity and innovation, leading to significant advancements in their respective fields.
Conclusion
Enrico G. Picozza’s contributions to the field of nucleic acid amplification through his inventive methods and apparatus have set a standard in biotechnological innovations. His work at PerkinElmer Corporation, along with fruitful collaborations, continues to push the boundaries of science, providing tools that are vital for research and clinical applications alike.